Global Single Cell RNA Sequencing Market Growth (Status and Outlook) 2025-2031

The global Single Cell RNA Sequencing market size is predicted to grow from US$ 3229 million in 2025 to US$ 10700 million in 2031; it is expected to grow at a CAGR of 22.1% from 2025 to 2031.

Single-cell RNA sequencing (scRNA-seq) is a genomic technology that allows researchers to study gene expression at the level of individual cells. It involves isolating and sequencing the RNA from individual cells, providing a snapshot of the genes being actively transcribed in each cell. This technique has revolutionized the field of transcriptomics by enabling researchers to examine cellular heterogeneity and discover rare cell populations.

United States market for Single Cell RNA Sequencing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Single Cell RNA Sequencing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Single Cell RNA Sequencing is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Single Cell RNA Sequencing players cover PerkinElmer, Illumina, Dolomite Bio, TAKARA BIO, Thermo Fisher, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Single Cell RNA Sequencing Industry Forecast” looks at past sales and reviews total world Single Cell RNA Sequencing sales in 2024, providing a comprehensive analysis by region and market sector of projected Single Cell RNA Sequencing sales for 2025 through 2031. With Single Cell RNA Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Single Cell RNA Sequencing industry.

This Insight Report provides a comprehensive analysis of the global Single Cell RNA Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Single Cell RNA Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Single Cell RNA Sequencing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Single Cell RNA Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Single Cell RNA Sequencing.

This report presents a comprehensive overview, market shares, and growth opportunities of Single Cell RNA Sequencing market by product type, application, key players and key regions and countries.

Segmentation by Type:
Non-Coding RNA Sequencing
Direct RNA Sequencing

Segmentation by Application:
Research Institutions
Bioscience Companies
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
PerkinElmer
Illumina
Dolomite Bio
TAKARA BIO
Thermo Fisher
Roche
Oxford Nanopore Technologies
Qiagen
LC Sciences
Pacific Biosciences

Please note: The report will take approximately 2 business days to prepare and deliver.